Related Experiment Video
Updated: Sep 28, 2025

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Rixosomal RNA degradation contributes to silencing of Polycomb target genes
Haining Zhou1, Chad B Stein2, Tiasha A Shafiq1
1Howard Hughes Medical Institute, Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Abstract:
Polycomb repressive complexes 1 and 2 (PRC1 and PRC2) are histone-modifying and -binding complexes that mediate the formation of facultative heterochromatin and are required for silencing of developmental genes and maintenance of cell fate1-3. Multiple pathways of RNA decay work together to establish and maintain heterochromatin in fission yeast, including a recently identified role for a conserved RNA-degradation complex known as the rixosome or RIX1 complex4-6. Whether RNA degradation also has a role in the stability of mammalian heterochromatin remains unknown. Here we show that the rixosome contributes to silencing of many Polycomb targets in human cells. The rixosome associates with human PRC complexes and is enriched at promoters of Polycomb target genes. Depletion of either the rixosome or Polycomb results in accumulation of paused and elongating RNA polymerase at Polycomb target genes. We identify point mutations in the RING1B subunit of PRC1 that disrupt the interaction between PRC1 and the rixosome and result in diminished silencing, suggesting that direct recruitment of the rixosome to chromatin is required for silencing. Finally, we show that the RNA endonuclease and kinase activities of the rixosome and the downstream XRN2 exoribonuclease, which degrades RNAs with 5' monophosphate groups generated by the rixosome, are required for silencing. Our findings suggest that rixosomal degradation of nascent RNA is conserved from fission yeast to human, with a primary role in RNA degradation at facultative heterochromatin in human cells.
Insights
The rixosome (RIX1 complex) aids in silencing Polycomb targets in human cells by degrading nascent RNA at facultative heterochromatin, a conserved mechanism from yeast.
Area of Science:
- Epigenetics and Gene Regulation
- RNA Biology
- Chromatin Structure
Background:
- Polycomb repressive complexes (PRC1 and PRC2) establish facultative heterochromatin and silence developmental genes.
- RNA decay pathways are crucial for heterochromatin maintenance in fission yeast, involving the rixosome (RIX1 complex).
- The role of RNA degradation in mammalian heterochromatin stability was previously unknown.
Purpose of the Study:
- To investigate the role of the rixosome (RIX1 complex) in mammalian heterochromatin formation and stability.
- To determine if RNA degradation contributes to the function of Polycomb repressive complexes in human cells.
Main Methods:
- Depletion of rixosome and Polycomb proteins using genetic manipulation.
- Chromatin immunoprecipitation to assess protein enrichment at target gene promoters.
- Analysis of RNA polymerase activity and gene expression.
- Site-directed mutagenesis to disrupt protein-protein interactions.
Main Results:
- The rixosome associates with human PRC complexes and localizes to Polycomb target gene promoters.
- Depletion of rixosome or Polycomb leads to increased RNA polymerase accumulation at target genes.
- Mutations in RING1B disrupt PRC1-rixosome interaction and impair gene silencing.
- Rixosome and XRN2 activities are essential for Polycomb-mediated gene silencing.
Conclusions:
- The rixosome plays a conserved role in RNA degradation at facultative heterochromatin in human cells.
- Rixosomal degradation of nascent RNA is required for Polycomb-mediated gene silencing.
- Direct recruitment of the rixosome to chromatin by PRC1 is critical for heterochromatin stability.
Related Concept Videos
Experimental RNAi
Regulation of Expression at Multiple Steps
MicroRNAs
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

